Medical Devices Startups

Elypta develops a metabolism-based liquid biopsy that measures the GAGome, a set of biomarkers of tumor metabolism, and applies machine learning to noninvasively detect cancer signatures. The company focuses on early cancer detection to reduce cancer mortality.

5 investors

EndoGastric Solutions offers the Transoral Incisionless Fundoplication (TIF 2.0) procedure and the EsophyX device used to treat GERD, along with reimbursement and technical/administrative support (TAP program) for medical practices. The company, now associated with Merit Medical, serves gastroenterology and surgical providers performing anti-reflux procedures.

5 investors

Envisagenics uses AI-driven analysis of RNA splicing to discover novel drug targets for immuno-oncology and neurodegenerative diseases. The company combines RNA biology expertise with machine learning to advance precision medicines.

5 investors

Exact Imaging develops the ExactVu micro-ultrasound platform, a 29 MHz imaging system that lets urologists perform real-time targeted and systematic prostate biopsies within a standard workflow. The platform supports both high-resolution and conventional transducers for prostate, abdominal, and testicular imaging, and serves clinical urology in the EU, US, and Canada.

5 investors

Exo is a company backed by leading venture capital and corporate investors focused on innovative technologies, with particular emphasis on healthcare, bioelectronic medicines, materials science, and deep technology solutions.

5 investors

Ferronova develops magnetic iron-oxide nanoparticle tracers (FerroTrace) and related imaging and therapy technologies to detect and map lymph nodes and tumours in early-stage cancers, supporting surgeons, oncologists and pathologists in staging and treating cancers such as oral, colorectal, esophageal, prostate and pancreatic. Spun out from the University of South Australia and Victoria University, the company is based in Australia.

5 investors

Finch Therapeutics is a life sciences company focused on the development and protection of drug-related intellectual property and therapeutics within the biotechnology and pharmaceutical industry.

5 investors

Fluid Biomed develops the ReSolv stent, a hybrid polymer-metal, self-expanding flow-diverting stent designed to treat brain aneurysms and reduce the risk of rupture and stroke. The device uses a dissolving polymer scaffold to promote blood vessel healing and simplify non-invasive follow-up imaging, and is currently limited to authorized clinical investigations.

5 investors

Fore Biotherapeutics is a clinical-stage oncology company developing targeted cancer therapies, including its lead plixorafenib program. It runs clinical trials such as the Forte Trial and offers expanded access programs for patients.

5 investors

Frontier Bio develops tissue engineering and bioprinting technology, including fabrication of tissue-engineered blood vessels for clinical and in vitro applications. The company works at the intersection of biology and engineering in the biotech and medical device space.

5 investors

Genoa Healthcare operates full-service pharmacies located inside mental health and community clinics, offering medication management for people with complex needs. It serves consumers with mental health conditions, assisted living residents, and those treating or preventing HIV/AIDS across pharmacies in 48 U.S. states and D.C.

5 investors

Pearl develops AI diagnostic support software for dental providers that analyzes x-rays and imaging to improve diagnosis accuracy, patient communication, and clinic operations. The platform serves dental practices globally and extends beyond diagnostic imaging to support clinic management and outcomes.

5 investors

HelpWear develops HeartWatch, a medical-grade ambulatory ECG monitor with a novel dry-electrode design for extended wear in cardiac arrhythmia detection and patient monitoring.

5 investors

Hypervision Surgical develops an intraoperative hyperspectral imaging system that uses AI to provide real-time, contrast-free tissue characterisation during surgery. The technology is designed to help surgeons visualise and assess tissue properties, improving surgical precision and patient safety.

5 investors

Ilara Health provides primary care and community medical clinics across Africa with tools to deliver care, including financing for diagnostic equipment and medicines and software to digitize clinic operations. It offers end-to-end solutions supporting the patient journey in healthcare.

5 investors

Imago Rehab provides at-home rehabilitation for people recovering from neurological or cardiovascular conditions, using one-on-one therapy delivered via telerehabilitation combined with robotic devices, gamification, and an integrated care team. The company serves patients seeking to regain strength, mobility, and independence outside of traditional outpatient rehab facilities.

5 investors

Inato operates a platform that connects patients with clinical trials in their communities, improving access and diversity in medical research. The company works with pharmaceutical companies and clinical trial sites to accelerate trial recruitment and enrollment.

5 investors

Inceptive builds foundation models of biological systems for drug discovery, specializing in sequence-based medicines like mRNA and peptides. The company combines deep learning trained on heterogeneous life data with in-house wet lab validation to design novel drug candidates that outperform existing options.

5 investors

Inner Cosmos develops a minimally invasive brain-computer interface, described as a "digital pill," aimed at treating depression. The company has run an FDA-approved clinical trial for depression and publishes research on its neurotechnology.

5 investors

Insmed is a biopharmaceutical company that provides grants and charitable funding to support healthcare provider education and patient care initiatives focused on nontuberculous mycobacterial lung disease, non-cystic fibrosis bronchiectasis, and other serious lung diseases.

5 investors

Intuitive develops robotic-assisted surgical systems, including the da Vinci systems for minimally invasive surgery and the Ion system for bronchoscopy. Its products are used by surgeons and physicians in hospitals and healthcare settings.

5 investors

Inventiva is a clinical-stage biopharmaceutical company developing drug candidates, with a focus on liver and other diseases. The page presents investor relations content including financial results and corporate governance updates.

5 investors

iOnctura is a clinical-stage drug development company developing precision oral small-molecule therapies targeting the tumor-stroma-immune interface, with a pipeline including roginolisib and cambritaxestat in cancers such as uveal melanoma and pancreatic cancer. It serves oncology patients through low-toxicity therapies aimed at extending healthspan.

5 investors

Karius is a company that provides microbial cell-free DNA (mcfDNA) metagenomic sequencing services for research and clinical applications. The company runs an Investigator-Initiated Studies grants program to support independent research on diagnostic testing outcomes, health economics, and fundamental science related to its sequencing technology.

5 investors